Review
Open access
Sep 2026
Lipid-Based Nanotherapeutics for Inflammatory Disorders: Current Progress and Future Perspectives.
The molecular mechanisms by which LBNCs' architecture modulates key inflammatory regulators, such as cytokine networks and oxidative pathways, to achieve superior therapeutic control are analyzed, positioning LBNCs as a transformative paradigm for refining the precision and efficacy of modern anti-inflammatory therapy.
Yumna Zaheer, Syeda Zunaira Bukhari, Unqa Mustafa et al.
· Wiley Interdisciplinary Revi... · 0 citations